Copyright
©The Author(s) 2019.
World J Nephrol. Feb 21, 2019; 8(2): 33-43
Published online Feb 21, 2019. doi: 10.5527/wjn.v8.i2.33
Published online Feb 21, 2019. doi: 10.5527/wjn.v8.i2.33
Table 1 Baseline characteristics n (%)
| Characteristics | All | eGFR (mL/min/1.73 m2) | P-value | |||
| ≥ 90 | 60-89 | 30-59 | < 30 | |||
| N | 13192 | 2979 (22.6) | 4870 (36.9) | 4397 (33.3) | 946 (7.2) | |
| Age (yr), mean ± SD | 60.7 ± 10.3 | 54.1 ± 8.5 | 59.4 ± 9.6 | 65.4 ± 9.2 | 66.0 ± 10.0 | < 0.001 |
| Male | 4012 (30.4) | 860 (28.9) | 1587 (32.6) | 1303 (29.6) | 262 (27.7) | < 0.001 |
| Duration of diabetes (yr), mean ± SD | 7.4 ± 4.8 | 6.1 ± 4.1 | 7.0 ± 4.5 | 8.3 ± 5.1 | 9.1 ± 5.4 | < 0.001 |
| Waist circumference (cm), mean ± SD | 88.6 ± 10.4 | 88.9 ± 10.6 | 88.7 ± 10.3 | 88.5 ± 10.3 | 87.4 ± 101.6 | < 0.01 |
| Hypertension | 9741 (73.8) | 1935 (65.0) | 3466 (71.2) | 3575 (81.3) | 765 (80.9) | < 0.001 |
| Smoking | 467 (3.5) | 127 (4.3) | 203 (4.2) | 117 (2.7) | 20 (2.1) | < 0.001 |
| CAD | 621 (4.7) | 76 (2.6) | 205 (4.2) | 269 (6.1) | 71 (7.5) | < 0.001 |
| CVD | 273 (2.1) | 42 (1.4) | 94 (1.9) | 104 (2.4) | 33 (3.5) | < 0.001 |
| PAD | 24 (0.2) | 5 (0.2) | 5 (0.1) | 8 (0.2) | 6 (0.6) | < 0.01 |
| Antiplatelets | 8067 (61.4) | 1569 (52.9) | 2974 (61.3) | 2923 (66.8) | 601 (64.0) | < 0.001 |
| Metformin | 9756 (74.0) | 2592 (87.0) | 4066 (83.5) | 2894 (65.8) | 204 (21.6) | < 0.001 |
| Sulfonylurea | 8751 (66.3) | 2070 (69.5) | 3460 (71.0) | 2882 (65.5) | 339 (35.8) | < 0.001 |
| Insulin | 2866 (21.7) | 493 (16.5) | 765 (15.7) | 1050 (23.9) | 558 (59.0) | < 0.001 |
- Citation: Kaewput W, Thongprayoon C, Rangsin R, Ruangkanchanasetr P, Mao MA, Cheungpasitporn W. Associations of renal function with diabetic retinopathy and visual impairment in type 2 diabetes: A multicenter nationwide cross-sectional study. World J Nephrol 2019; 8(2): 33-43
- URL: https://www.wjgnet.com/2220-6124/full/v8/i2/33.htm
- DOI: https://dx.doi.org/10.5527/wjn.v8.i2.33